Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05315492
Other study ID # Vietnam Addiction Care
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 5, 2024
Est. completion date July 2026

Study information

Verified date May 2024
Source University of California, Los Angeles
Contact Li Li, PhD
Phone 13107942446
Email lililili@ucla.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to develop and test an intervention to enhance the addiction service continuum with the joint effort of commune health workers and family members of people who use drugs in Vietnam.


Description:

The study will develop and test an intervention to strengthen a continuum of addiction services. The intervention, entitled "Community Care Consortium (CCC)," features community health workers' joint effort with family members to provide patient-centered, individualized addiction care and support. The intervention will be developed and tested through three phases in three regions of Vietnam (Ninh Binh, Da Nang, and Can Tho). In Phase 1, we will conduct formative studies with commune (community) health workers (CHW), community representatives, PWUD, and their family members to identify barriers to addiction service utilization and discuss potential strategies to establish a continuum of addiction services. Based on the formative study findings, the CCC Intervention and its implementation plans will be developed through workgroup meetings with researchers, community members, and target users. In Phase 2, the CCC Intervention will be piloted in three communes and revised based on acceptability/feasibility data, process evaluation, and feedback from field staff and participants. In Phase 3, a randomized controlled trial of the CCC Intervention will be conducted in 60 communes, which will be randomized to either an intervention condition or a control condition (30 communes in each condition). A total of 720 PWUD, 720 of their family members, and 180 commune health workers (CHW) will participate in the study. The intervention outcomes on PWUD, CHW, and family members will be assessed with the data collected at baseline, 3-, 6-, 9- and 12-month follow-ups.


Recruitment information / eligibility

Status Recruiting
Enrollment 1620
Est. completion date July 2026
Est. primary completion date January 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18 or older - Having a history of drug use - Having disclosed drug using status to at least one of his/her family members and is willing to invite this family member to our study - Currently residing in the selected communes - Voluntary written informed consent Exclusion Criteria: - Inability to give informed consent

Study Design


Intervention

Behavioral:
Community Care Consortium (CCC)
The intervention will train community health workers to take an active role in the drug control and addiction service delivery in the community.

Locations

Country Name City State
Vietnam National Institute of Hygiene and Epidemiology Hanoi
Vietnam Community Health Centers Ninh Bình

Sponsors (1)

Lead Sponsor Collaborator
University of California, Los Angeles

Country where clinical trial is conducted

Vietnam, 

Outcome

Type Measure Description Time frame Safety issue
Other Family members' support in the 4 domains:Seek,Test, Treat, Retain Family member's emotional, informational, monetary support, logistic assistance for PWUD treatment and retention as well as scale measures in their caregiver burden and coping. Changes from baseline to 3-, 6-, 9- and 12- month follow-ups
Primary PWUD's STTR fulfillment score This overall score consists of individual indicators in 4 domains: Seek,Test, Treat, Retain Changes from baseline to 3-, 6-, 9- and 12- month follow-ups
Secondary CHW's addiction-related service provision and support CHW's service provision and support such as patient referrals and support for treatment retention measured by frequencies of appointment reminder, follow-up activities Changes from baseline to 3-, 6-, 9- and 12- month follow-ups
See also
  Status Clinical Trial Phase
Recruiting NCT04276792 - Community Opioid Innovation Network (JCOIN): TCU Clinical Research Center N/A
Active, not recruiting NCT05343793 - Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT) N/A
Not yet recruiting NCT05908305 - Impact of Tramadol Addiction On Dental Anesthesia Success Phase 4